IP Reserch and Use of IP Case Studies for Educational Purposes: Views and Challenges Geneva, April 26-29, 29, 2011

Similar documents
The TRIPS Agreement and Patentability Criteria

Carnegie Endowment for International Peace

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

What s in the Spec.?

Essay No. 1 ~ WHAT CAN YOU DO WITH A NEW IDEA? Discovery, invention, creation: what do these terms mean, and what does it mean to invent something?

Slide 15 The "social contract" implicit in the patent system

WIPO-WTO Colloquium for Teachers of Intellectual Property

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

Software Patent Issues

WIPO-WTO COLLOQUIUM FOR TEACHERS OF INTELLECTUAL PROPERTY

Patent application strategy when, where, what to file?

Intellectual Property Law Alert

INTELLECTUAL PROPERTY POLICY

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

Overview on Patent Reforms in South Africa. Mr Trod Lehong 14 September 2017 Adams & Adams

Access to Medicines, Patent Information and Freedom to Operate

Intellectual Property and Sustainable Development

First to Invent vs. First to File: The Impact of an Old Dilemma on the Future of Biotechnology and Pharmaceutical Discoveries

AIPPI Forum Helsinki 2013 Workshop IV Digital Gaming and IP

WORLD TRADE ORGANIZATION ADVANCED COURSE. WIPO-WTO/ADV/ACAD/13/INF1.PROV ORIGINAL: English DATE: XXXX

Utility Utilit Model Sy Model S stem in China

Draft Manual Of Patent Practice And Procedure (2008) Patent Office India

CS 4984 Software Patents

A POLICY in REGARDS to INTELLECTUAL PROPERTY. OCTOBER UNIVERSITY for MODERN SCIENCES and ARTS (MSA)

WIN In-House Counsel Day Melbourne

5/30/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota

IPRs and Public Health: Lessons Learned Current Challenges The Way Forward

Developing Countries in the Globalization of Pharmaceutical Patenting

Key issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP

Functionality of the Nagoya ABS Protocol with a view to AnGR and a side-look to Anti- Conterfeiting Trade Agreement (ACTA)

What is Intellectual Property?

WORLD TRADE ORGANIZATION

FÉDÉRATION INTERNATIONALE DES CONSEILS EN PROPRIÉTÉ INDUSTRIELLE. 24 February 2011 Via electronic filing

Intellectual Property

GENEVA INTERGOVERNMENTAL COMMITTEE ON INTELLECTUAL PROPERTY AND GENETIC RESOURCES, TRADITIONAL KNOWLEDGE AND FOLKLORE

University Technology Transfer, Innovation Ecosystem and EIE Project

The 45 Adopted Recommendations under the WIPO Development Agenda

SUPPORT NOTES UNIT 3: INSIDE THE LINES

Department of Intellectual Property

Statement of. Hon. General J. Mossinghoff Senior Counsel Oblon, Spivak, McClelland, Maier & Neustadt, P.C. before the

Pharma Session 4: Digital health your health on (the) line

Distance Learning Program 13 courses from 1999(8)- 2010: 200,000 participants

PREP Course 32: Intellectual Property (IP) in Research Kirk R. Manogue, PhD Vice President, Technology Transfer

The Enterprise Europe Network. in Hungary Zita Majoros, Consultant. Title. Sub-title. 28 th January, Kiev, Ukraine

How To Draft Patents For Future Portfolio Growth

Software Patents in the European Union

Common evaluation criteria for evaluating proposals

19 Progressive Development of Protection Framework for Pharmaceutical Invention under the TRIPS Agreement Focusing on Patent Rights

Standing Committee on the Law of Patents Twenty-Sixth Session

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

New Draft Manual Of Patent Practice And Procedure - Patent Office India (2008) >>>CLICK HERE<<<

LEGISLATIVE OPTIONS FOR TK AND

CBD Request to WIPO on the Interrelation of Access to Genetic Resources and Disclosure Requirements

WIPO REGIONAL SEMINAR ON SUPPORT SERVICES FOR INVENTORS, VALUATION AND COMMERCIALIZATION OF INVENTIONS AND RESEARCH RESULTS

RECENT DEVELOPMENTS IN THE IMEC IP BUSINESS

Impact of international cooperation and science and innovation strategies on S&T output: a comparative study of India and China

BIPF Munich. South Africa Enforcement of Pharmaceutical Patents and the New Draft IP Policy

5 th Annual Pharma IPR Conference 2016

WIPO Development Agenda

UNCITRAL Third International Colloquium on Secured Transactions Session on Contractual Guide on IP Licensing (Vienna, March 3, 2010)

Questionnaire May Q178 Scope of Patent Protection. Answer of the French Group

MPEP Breakdown Course

WIPO Development Agenda

International Patent Regime. Michael Blakeney

Topic 2: The Critical Role of IP Policies in Modern Economies

I. The First-to-File Patent System

Flexibilities in the Patent System

An overview of India's approach to key IP issues at home and abroad. Dr. Bona Muzaka King s College London

China: Managing the IP Lifecycle 2018/2019

Subregional Seminar on the Legal Protection of Biotechnology and Genetic Resources Banska Bystrica, May 2 and 3, Access and Benefit Sharing

Intellectual Property

PATENT PROTECTION IN FRANCE

California State University, Northridge Policy Statement on Inventions and Patents

Policy Contents. Policy Information. Purpose and Summary. Scope. Published on Policies and Procedures (

Topic5 Advantages and Limitations of the PCT System from the User Perspective

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants

Patent Agenda. Egyptian National Group of AIPPI

America Invents Act. What does it mean for you?

Requirements for Description. Japan Patent Office

Retail is becoming more and more. Finding the best protection for retail spaces 3D DESIGNS

Half-Day Seminar on. Life Sciences Patent Protection in US and India

_ To: The Office of the Controller General of Patents, Designs & Trade Marks Bhoudhik Sampada Bhavan, Antop Hill, S. M. Road, Mumbai

Patent Statistics as an Innovation Indicator Lecture 3.1

COMPETITIVE INTELLIGENCE USING INTELLECTUAL PROPERTY INFORMATION

Towards a New IP Consciousness in Universities and R&D Institutions: Case Show

Patents as a regulatory tool

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

INTER-REGIONAL REGIONAL FORUM ON DEVELOPMENT AND SERVICE-ORIENTED INTELLECTUAL PROPERTY (IP) ADMINISTRATION

11th Annual Patent Law Institute

Overview of Intellectual Property Policy and Law of China in 2017

TRAINING SEMINAR PHARMACEUTICALS AND INTELLECTUAL PROPERTY ACCESS TO MEDICINE: Exploitation of pharmaceutical patents: compulsory licences SESSION 4

Bangkok, August 22 to 26, 2016 (face-to-face session) August 29 to October 30, 2016 (follow-up session) Claim Drafting Techniques

The Nagoya Protocol: Compliance. Implications of the E.U. law for Microbiologists

PATENTING. T Technology Management in the Telecommunications Industry Aalto University

Intellectual Property Management - How to capture, protect and exploit your ideas

World Trade Organization Regional Workshop, Hong Kong, November 11 to 13, 2014

THE ASEAN FRAMEWORK AGREEMENT ON ACCESS TO BIOLOGICAL AND GENETIC RESOURCES

Patentable Subject Matter & Patent Policy. Introduction to Intellectual Property Law & Policy Professor Wagner

11th Annual Patent Law Institute

CO-ORGANISERS: Page 1 of 13

Transcription:

IP Reserch and Use of IP Case Studies for Educational Purposes: Views and Challenges Geneva, April 26-29, 29, 2011 Altaye Tedla Head, Distance Learning Program WIPO Academy 2 Outline Introduction to IP Case Studies Commissioned case studies and case studies on Landmark decisions by different courts Reinforce the legal, economic, and policy considerations of the rule of IP law Illustrate the increasing use of strategic IP management based on collaborative and competitive models. Part of Instructional Design- Advanced anchoring of learner knowledge, recollection, and confidence in applying legal principles and creating new knowledge. How do we develop Case Studies: Customization of courses by IP Offices using local case studies, Provision by tutors in their discussion forum, Landmark Cases that are internationally recognized.

Introduction: IP Case Studies for various levels of teaching and research 3 Business/ public policy/global NT CR P TM ID UC Practical Skills Drafting Licensing Disputes Settlement Three Dimensions! Theory (Cases on principles) Examination, Drafting, Licensing based cases. (Cases with IP administration merit) Diamond V Chakrabarty (447 U.S. 303 (1980) 4 Where as live, human-made micro-organisms, or their parts were generally thought to be outside the scope of patentable subject matter, after the Dimond V. Chakrabarty decision on patenting life forms that are isolated from nature by man with specific function, use and benefit has expanded and many IP Offices have established rules (US, EU, Japan, Australia, India) Chakrabarty s claim for process and the bacteria was partly rejected by examiner. He appealed to the Court of Customs and Patent Appeals which overturned the case in favour of Chakrabarty- "the fact that micro-organisms are alive is without legal significance for purposes of the patent law

Diamond V Chakrabarty (447 U.S. 303 (1980) 5 Sidney A. Diamond, Commissioner of Patents and Trademarks, appealed to the Supreme Court in light of earlier decisions under under the 1930 and 1970 Plant Variety Protection Act 1. that micro-organisms are products of nature and 2. that as living things they are not patentable subject matter. Supreme Court held ( protest ): anything under the sun that is made by man to be eligible for patenting. Chakrabarty s microorganism constitutes a "manufacture" or "composition of matter - therefore patentable subject matter. With 5-to-4 margin the dissenters held that this was a charged social issue and its implications on genetic engineering of all life forms, it should be Congress that should make the decision. However, the majority disagreed and went on to rule on the case. Diamond V Chakrabarty (447 U.S. 303 (1980) 6 Diamond versus Chakrabarty case declared that the "relevant distinction is not between animate and inanimate things but whether living products could be seen as human-made inventions". This decision by the US Supreme Court heralded a new era in which living organisms could be patented (E.g Harvard Oncomouse). Directives and Guidelines were established in order to clarify what such decisions meant. (EPO, JPO, and USPTO formed a Trilateral Cooperation project discussing the patentability of genetic inventions, as a result of comparative studies using a hypothetical cases, 1999)

Diamond V Chakrabarty (447 U.S. 303 (1980) 7 The recent USPTO guidelines observe that an inventor's discovery of a gene can be the basis for a patent on the genetic composition isolated from its natural state and processed through purifying steps that separate the gene from other molecules naturally associated with it. The guidelines distinguish two illustrative cases: a patent application only disclosing the nucleic acid molecular structure for a newly discovered gene, with no utility for the claimed isolated gene this would not be patentable; such a patent application in which the inventor also discloses a use of the purified gene isolated from its natural state this could be eligible for a patent. Diamond V Chakrabarty (447 U.S. 303 (1980) 8 The European Commission (EC) Biotechnology Directive (98/44/EC) adopted in 1998 aimed to clarify the principles of patent laws in member States of the Community which are applicable to biotechnological inventions with a view to harmonizing patent laws in the EU. inventions which are new, which involve an inventive step and which are susceptible of industrial application shall be patentable even if they concern a product consisting of or containing biotechnological material or a process by means of which biotechnological material is produced, processed or used, and biological material which is isolated from its natural environment or produced by means of a technical process may be the subject of an invention even if it previously occurred in nature.

Commissioned Case Studies in the Academy s Programs: Hoodia Plant1 (January 2008) 9 This concerns a dispute and subsequent partnership between the San people in Sout Africa and pharmaceutical companies in developed countries over the ownership and the right to commercially exploit as well as benefit sharing of the use of Hoodia plant which contains traditional medicinal knowledge and patentable active components. An appetite-suppressant drug developed by pharmaceutical companies are faced with counterfeiting drugs. The case involves several players in different countries and poses a number of questions on IP management, transfer of technology and knowledge between the North and the South and mutually beneficial and sustainable partnerships of all the parties. Commissioned Case Studies in the Academy s Programs: Black Berry Case (Patent) Ethiopian Government and Starbucks Dispute over Coffee designation names (Trademark and Geographical Design) 10

11 Use of IP Case Studies in the Learning Process Case Studies serve as the main anchors, to demonstrating IP in practice. Case Studies reinforce the teaching of the balance of IP between the societal benefits and private property Needs Analysis Instructional Design Objectives Conditioning of Learning Teaching Methods The Learner IP Case Studies Deep Approach Surface Approach Strategic Approach Knowledge Seekers Understanding Seekers Versatile Learners Self-confidence Evaluation and Assessment Motivations (aims, interests, concerns ) Learning Skills and Preferences Increases learner Capacity for selfdirection Persistence 12 Learner Centred Approach- (over 4,000 hrs of course development for each 50 hr of learning)

Case studies are critical in teaching IP and its practical use 13 1. Differentiate Effective strategic use of IP requires that many different elements of a situation be evaluated at once. When analyzing cases, it is important to isolate legal principles, other critical facts, evaluate whether assumptions are useful or faulty, and to distinguish between good and bad information. Case studies are critical in teaching IP and its practical use 14 2. Speculate Being able to imagine different scenarios or contemplate the outcome of a decision can aid the analysis. Case materials often seem to be missing data or the information provided is contradictory. An ability to speculate about details that are unknown or the consequences of an action can be helpful. (A real life situation)

Case studies are critical in teaching IP and its practical use 15 3. Integrate Strategy- involves looking at the big picture and having wider perspective. Integration involves comprehending how all the factors of a case will interact. Changes made in policy or national strategy one area affects other parts of the use of IP. Thus, a holistic perspective that integrates the impact of various decisions and environmental influences on all competitors are needed." Commissioned Case Studies in the Academy s Programs: Black Berry Case (Patent) Ethiopian Government and Starbucks Dispute over Coffee designation names (Trademark and Geographical Design) 16

Dess, Lumpkin and Eisner (Strategic Management: Text and Cases) note that Case Studies allow: 17 1. Keep an open mind. 2. Take a stand for what you believe. 3. Draw on your personal experience. 4. Participate and persuade. 5. Be concise and to the point. 6. Think out of the box. 7. Learn from the insights of others. 8. Apply insights from other case analyses. 9. Critically analyze your own performance. 10. Conduct outside research. Challenges: 18 1. Lack of access to court decisions in developing countries 2. Customizing case studies for development purposes 3. Fundamental changes in interpretation of the IP Law 4. Learners from civil law and common law practices have different expectations 5. Access to publications and publishing by learners in developing countries (Less research in DC)

Thank You 19